Innovative Abdominal Tourniquet Device Enhances Survival for Women with Postpartum Hemorrhage

A new study reveals that the Abdominal Aortic and Junctional Tourniquet–Stabilized (AAJT-S) drastically improves control of postpartum hemorrhage, saving lives in emergency situations worldwide.
A groundbreaking study introduces a new approach to managing severe postpartum hemorrhage (PPH), which is the leading cause of maternal death worldwide. The research, published in the International Journal of Gynecology & Obstetrics, examines the use of the Abdominal Aortic and Junctional Tourniquet–Stabilized (AAJT-S), a device designed for emergency hemorrhage control. Led by Dr. Yevheniia Poliakova from Olexandrivska Hospital and Dr. Viktor Oshovskyy from Uniklinika Medical Center, the study involved four women experiencing uncontrollable bleeding due to uterine atony, despite receiving standard treatments like uterotonics and balloon tamponade.
The AAJT-S was applied to the abdomen of each patient, successfully halting bleeding in less than two minutes without device-related complications. The device features an inflatable, wedge-shaped bladder that, when expanded, compresses blood vessels and temporarily stops blood flow, providing crucial time for surgical intervention. It remained in place for up to 45 minutes, facilitating blood transfusions and preparations for definitive treatments.
This device’s portability and ease of use make it particularly valuable in low-resource settings, where delays in care can be fatal. Dr. Poliakova emphasized that the AAJT-S offers a new lifeline, especially in combat or disaster zones, by giving healthcare providers a critical window to stabilize patients.
In practical terms, the device can be quickly positioned over the umbilicus after delivery, inflates to occlude blood flow, and deflates when bleeding ceases. One patient was able to recover fully after device removal, avoiding surgery altogether, while others used it as a bridge to further care. Researchers highlight that early bleeding control is vital, and devices like the AAJT-S could significantly improve maternal survival rates globally.
Scott Dodson, CEO of Compression Works, noted that this innovation bridges trauma care and obstetrics, proving its potential as a universal hemorrhage control platform. The study underscores the importance of rapid, reliable interventions in emergency maternity care and demonstrates that solutions like the AAJT-S can be deployed effectively by minimally trained personnel, saving lives in critical moments.
In conclusion, this study signifies a major step forward in emergency obstetric management, especially for women facing life-threatening bleeding in resource-limited environments. The authors suggest that broader adoption of such devices could transform maternal health outcomes worldwide.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Parents Beware: Misleading Claims from Companies Banking Baby Teeth for Stem Cell Treatments
Parents are investing in tooth stem cell banking for their children's future, but companies' claims about treatment potential are unproven and misleading, raising concerns among experts about overhyped promises and lack of evidence.
Potential of Cholesterol-Lowering Drugs as a New Treatment for Liver Cancer
Research reveals that atorvastatin, a common cholesterol-lowering medication, may be repurposed as an effective treatment for liver cancer, offering hope for improved therapies and patient survival.
How the Side of Onset in Parkinson's Disease Influences Its Progression
Recent research highlights how the side of initial symptoms in Parkinson's disease significantly impacts cognitive, emotional, and psychiatric outcomes, emphasizing personalized treatment approaches.